Jeil Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.82%

Jeil Pharmaceutical Co Ltd (271980) has an Asset Resilience Ratio of 0.82% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩4.11 Billion

≈ $2.79 Million USD Cash + Short-term Investments

Total Assets

₩501.66 Billion

≈ $339.97 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how Jeil Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check 271980 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Jeil Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 271980 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩4.11 Billion	0.82%
Total Liquid Assets	₩4.11 Billion	0.82%

Asset Resilience Insights

Limited Liquidity: Jeil Pharmaceutical Co Ltd maintains only 0.82% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jeil Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jeil Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for Jeil Pharmaceutical Co Ltd (2018–2024)

The table below shows the annual Asset Resilience Ratio data for Jeil Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.76%	₩3.98 Billion ≈ $2.70 Million	₩525.70 Billion ≈ $356.26 Million	+0.21pp
2023-12-31	0.55%	₩2.67 Billion ≈ $1.81 Million	₩487.33 Billion ≈ $330.25 Million	+0.52pp
2022-12-31	0.03%	₩142.46 Million ≈ $96.54K	₩456.89 Billion ≈ $309.63 Million	-0.45pp
2021-12-31	0.48%	₩2.04 Billion ≈ $1.38 Million	₩426.49 Billion ≈ $289.02 Million	-0.18pp
2020-12-31	0.66%	₩2.69 Billion ≈ $1.83 Million	₩409.66 Billion ≈ $277.62 Million	+0.66pp
2019-12-31	0.00%	₩4.76 Million ≈ $3.23K	₩401.59 Billion ≈ $272.15 Million	-0.09pp
2018-12-31	0.09%	₩350.00 Million ≈ $237.19K	₩402.90 Billion ≈ $273.04 Million	--

pp = percentage points

About Jeil Pharmaceutical Co Ltd

KO:271980 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$93.12 Million

₩137.41 Billion KRW

Market Cap Rank

#19390 Global

#932 in Korea

Share Price

₩9430.00

Change (1 day)

+2.17%

52-Week Range

₩9230.00 - ₩17390.00

All Time High

₩104611.38